UK Fill-finish Pharmaceutical Contract Manufacturing Market Size & Outlook

The fill-finish pharmaceutical contract manufacturing market in UK is expected to reach a projected revenue of US$ 689.9 million by 2030. A compound annual growth rate of 6.3% is expected of UK fill-finish pharmaceutical contract manufacturing market from 2024 to 2030.
Revenue, 2023 (US$M)
$450.0
Forecast, 2030 (US$M)
$689.9
CAGR, 2024 - 2030
6.3%
Report Coverage
UK

UK fill-finish pharmaceutical contract manufacturing market, 2018-2030 (US$M)

UK

Related Markets

UK fill-finish pharmaceutical contract manufacturing market highlights

  • The UK fill-finish pharmaceutical contract manufacturing market generated a revenue of USD 450.0 million in 2023 and is expected to reach USD 689.9 million by 2030.
  • The UK market is expected to grow at a CAGR of 6.3% from 2024 to 2030.
  • In terms of segment, large molecules was the largest revenue generating molecule type in 2023.
  • Small molecules is the most lucrative molecule type segment registering the fastest growth during the forecast period.


Fill-finish pharmaceutical contract manufacturing market data book summary

Market revenue in 2023USD 450.0 million
Market revenue in 2030USD 689.9 million
Growth rate6.3% (CAGR from 2023 to 2030)
Largest segmentLarge molecules
Fastest growing segmentSmall molecules
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationLarge Molecules, Small molecules
Key market players worldwideBoehringer Ingelheim, Catalent Inc, Baxter International Inc, Eurofins Scientific SE, Recipharm, Fresenius SE & Co KGaA, Novartis AG ADR, Recro Pharma, Symbiosis Pharmaceutical Services, MabPlex International


Other key industry trends

  • In terms of revenue, UK accounted for 4.8% of the global fill-finish pharmaceutical contract manufacturing market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany fill-finish pharmaceutical contract manufacturing market is projected to lead the regional market in terms of revenue in 2030.
  • Germany is the fastest growing regional market in Europe and is projected to reach USD 822.6 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Fill-finish Pharmaceutical Contract Manufacturing Market Companies

Name Profile # Employees HQ Website

UK fill-finish pharmaceutical contract manufacturing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to fill-finish pharmaceutical contract manufacturing market will help companies and investors design strategic landscapes.


Large molecules was the largest segment with a revenue share of 67.09% in 2023. Horizon Databook has segmented the UK fill-finish pharmaceutical contract manufacturing market based on large molecules, small molecules covering the revenue growth of each sub-segment from 2018 to 2030.


In the UK, fill-finish contract manufacturing is an important part of the pharmaceutical industry. The number of CMOs that specialize in fill-finish contract manufacturing is growing in the UK owing to the increasing demand in the market.

These companies generally have state-of-the-art facilities and equipment, as well as highly skilled personnel, to ensure that products are manufactured as per the highest quality standards. One of the key advantages of using a CMO for fill-finish contract manufacturing is that it allows pharmaceutical companies to outsource a critical part of the manufacturing process, which can be costly and time-consuming to perform in-house.

By partnering with a CMO, pharmaceutical companies can benefit from the CMO's expertise, experience, and specialized equipment, while also reducing its capital expenditure. Overall, the fill-finish contract manufacturing scenario in the UK is robust and competitive, with a number of high-quality CMOs offering a range of services to pharmaceutical companies.

Reasons to subscribe to UK fill-finish pharmaceutical contract manufacturing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of UK fill-finish pharmaceutical contract manufacturing market databook

  • Our clientele includes a mix of fill-finish pharmaceutical contract manufacturing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the UK fill-finish pharmaceutical contract manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into UK fill-finish pharmaceutical contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

UK fill-finish pharmaceutical contract manufacturing market size, by molecule type, 2018-2030 (US$M)

UK Fill-finish Pharmaceutical Contract Manufacturing Market Outlook Share, 2023 & 2030 (US$M)

UK fill-finish pharmaceutical contract manufacturing market size, by molecule type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more